Expression and activity of caspases 1 and 3 in myelodysplastic syndromes
Authors:
Open Access
- 1 December 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (12) , 2045-2051
Abstract
Myelodysplastic syndromes (MDS) are characterized by abnormal growth of committed progenitors in clonogenic assay, with reduced number of colonies and decreased colony/cluster ratio. It has been suggested that excessive apoptosis is the cause of marrow failure in MDS. We studied the expression of caspase-1 (interleukin-1β-converting enzyme, ICE) and caspase-3 (CPP32/apopain) in marrow mononuclear cells, and the growth pattern of committed progenitors in a series of 83 MDS cases. The percentage of apoptotic cells as detected by TUNEL technique, and the percentage of caspase-3-positive cells were significantly higher in refractory anemia (RA) and RA with ringed sideroblasts (RAS) than in chronic myelomonocytic leukemia (CMML), refractory anemia with excess of blasts (RAEB) and RAEB in transformation (RAEB-T). Spontaneous growth of CFU-GM was associated with a higher percentage of blasts, and with a lower expression of caspase-3 and caspase-1. The yield of CFU-E, BFU-E, and CFU-GM (in the presence of growth factors) was decreased by comparison to normal marrow, but large individual differences were observed in all cytological categories. Inhibition of caspase-1 and caspase-3 activities by specific inhibitors resulted in a significant increase of the production of all types of colonies (up to 50-fold of control). In the presence of caspase-3 inhibitor, the number of BFU-E and CFU-E was in the range of normal values in most cases of RA and RAS. In addition, caspase-1 and -3 protease activities were detectable by fluorogenic assay in all cases studied. Western blot analysis confirmed the expression of caspase-3, including the cleaved (activated)-p17 form in most cases of RA/RAS analyzed. It is concluded that caspase-3 is implicated in the increased apoptosis observed in MDS and that inhibition of its activity can restore at least partially the growth of committed progenitors.Keywords
This publication has 23 references indexed in Scilit:
- ‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteinsBritish Journal of Haematology, 1998
- Caspases: the executioners of apoptosisBiochemical Journal, 1997
- Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromesLeukemia, 1997
- Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessmentLeukemia, 1997
- Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cellsBlood, 1996
- Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology, 1996
- Human ICE/CED-3 Protease NomenclatureCell, 1996
- New members of the Bcl-2 family and their protein partnersCurrent Opinion in Genetics & Development, 1996
- Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesisAmerican Journal of Hematology, 1995
- Apoptosis is a Common Histopathological Finding in Myelodysplasia: the Correlate of Ineffective HaematopoiesisLeukemia & Lymphoma, 1990